154 related articles for article (PubMed ID: 8956684)
1. The relationship between plasma haloperidol concentrations and clinical results.
Palao DJ; Araúxo A; Haro JM; Brunet M; Bernardo M
Arch Gen Psychiatry; 1996 Dec; 53(12):1167-9. PubMed ID: 8956684
[No Abstract] [Full Text] [Related]
2. The interpretation of plasma haloperidol concentrations.
Kirch DG; Bigelow LB; Wyatt RJ
Arch Gen Psychiatry; 1985 Aug; 42(8):838-40. PubMed ID: 4015329
[No Abstract] [Full Text] [Related]
3. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
[TBL] [Abstract][Full Text] [Related]
4. Plasma haloperidol levels: clinical response and fancy mathematics.
Van Putten T; Marder SR; Mintz J
Arch Gen Psychiatry; 1985 Aug; 42(8):835-8. PubMed ID: 4015328
[No Abstract] [Full Text] [Related]
5. Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.
Hollister LE; Kim DY
Am J Psychiatry; 1982 Nov; 139(11):1466-8. PubMed ID: 7137396
[TBL] [Abstract][Full Text] [Related]
6. Plasma drug level and clinical response.
Cooper TB; Volavka J; Czobor P
J Clin Psychopharmacol; 1992 Apr; 12(2):134-6. PubMed ID: 1573036
[No Abstract] [Full Text] [Related]
7. Beyond the therapeutic window: a case presentation.
Schulz SC; Butterfield L; Garicano M; Narasimhachari N; Friedel RO
J Clin Psychiatry; 1984 May; 45(5):223-5. PubMed ID: 6725212
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated drug holidays on serum haloperidol concentrations, psychiatric symptoms, and movement disorders in schizophrenic patients.
Newton JE; Cannon DJ; Couch L; Fody EP; McMillan DE; Metzer WS; Paige SR; Reid GM; Summers BN
J Clin Psychiatry; 1989 Apr; 50(4):132-5. PubMed ID: 2925601
[TBL] [Abstract][Full Text] [Related]
9. Plasma haloperidol levels and clinical response.
Smith RC
Arch Gen Psychiatry; 1987 Dec; 44(12):1110-2. PubMed ID: 3689100
[No Abstract] [Full Text] [Related]
10. Relationship of serum haloperidol levels to clinical response in schizophrenic patients.
Magliozzi JR; Hollister LE; Arnold KV; Earle GM
Am J Psychiatry; 1981 Mar; 138(3):365-7. PubMed ID: 7468835
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.
Lin KM; Poland RE; Nuccio I; Matsuda K; Hathuc N; Su TP; Fu P
Am J Psychiatry; 1989 Oct; 146(10):1307-11. PubMed ID: 2782476
[TBL] [Abstract][Full Text] [Related]
12. Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
Santos JL; Cabranes JA; Vazquez C; Fuentenebro F; Almoguera I; Ramos JA
Biol Psychiatry; 1989 Aug; 26(4):381-8. PubMed ID: 2669981
[TBL] [Abstract][Full Text] [Related]
13. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
[TBL] [Abstract][Full Text] [Related]
15. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
Levinson I; Levine S
Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
[No Abstract] [Full Text] [Related]
16. Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
Balant-Gorgia AE; Eisele R; Balant L; Garrone G
Eur Arch Psychiatry Neurol Sci; 1984; 234(1):1-4. PubMed ID: 6489392
[TBL] [Abstract][Full Text] [Related]
17. Haloperidol plasma levels and dose optimization.
Coryell W; Miller DD; Perry PJ
Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
Volavka J; Douyon R; Convit A; Czobor P; Cooper TB
Arch Gen Psychiatry; 1992 Dec; 49(12):999-1000. PubMed ID: 1449388
[No Abstract] [Full Text] [Related]
20. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]